/Humana%20Inc_%20logo%20on%20laptop-by%20monticello%20via%20Shutterstock.jpg)
Humana has recently outperformed the Healthcare sector, and Wall Street analysts are moderately optimistic about the stock’s prospects.
/Cencora%20Inc_%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Shares of Cencora have outperformed the broader healthcare sector over the past year, and Wall Street analysts are bullish about the stock’s prospects.
/Agilent%20Technologies%20Inc_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Agilent Technologies has lagged the healthcare sector over the past three months, but analysts are optimistic about the stock’s prospects.
/IQVIA%20Holdings%20Inc%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
IQVIA Holdings has underperformed other healthcare stocks over the past three months, but analysts are optimistic about the stock’s prospects.
You can build solid wealth with broad index funds -- or you might try to juice your returns with some superperformers.
/Edwards%20Lifesciences%20Corp%20Irvine%2C%20Ca%20campus-by%20Steve%20Cukrov%20via%20Shutterstock.jpg)
Edwards Lifesciences has recently underperformed the Healthcare sector, but Wall Street analysts anticipate a modest upside for the stock.
/Mckesson%20Corporation%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
McKesson has outperformed other healthcare stocks over the past three months, and analysts remain optimistic about the stock’s prospects.
/Medtronic%20Plc%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Despite Medtronic consistently underperforming the broader healthcare sector, Wall Street analysts remain cautiously optimistic about the stock’s outlook.
Gilead Sciences has underperformed the broader market YTD, but Wall Street analysts are still cautiously optimistic about the stock’s prospects.
